Brett Jeffrey Palmero

Brett Jeffrey Palmero

Auto-generated profile, based on publicly available information

Brett Jeffrey Palmero

Northwestern University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BPBrett Jeffrey Palmero
Brett Jeffrey Palmero
EGEmily Gamero
Emily Gamero
NMNiall Mangan
Niall Mangan
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek
A continual goal in metabolic engineering is directing pathway flux to desired products and avoiding loss of pathway intermediates to competing pathways. Encapsulation of the pathway is a possible solution, as it creates a diffusion barrier between pathway intermediates and competing enzymes. It is hypothesized that bacteria use organelles known as bacterial microcompartments - proteinaceous shells encapsulating a metabolic pathway - for this purpose. We aim to determine to what degree this hypothesized benefit is conferred to encapsulated pathways. To this end, we used bacterial microcompartments to encapsulate select enzymes from the violacein pathway, which is composed of five enzymes that produce violacein as the main product and deoxyviolacein as a side product. Importantly, we studied the pathway in a cell-free context, allowing us to hold constant the concentration of unencapsulated and encapsulated enzymes and increase our control over reaction conditions. The VioE enzyme is a branch point in that it makes the precursor for both violacein and deoxyviolacein, the VioC enzyme is required for production of deoxyviolacein, and the VioD enzyme is required for violacein production. When we encapsulated VioE and VioC and left VioD unencapsulated, the product profile shifted toward deoxyviolacein and away from violacein compared to when VioC and VioD were both unencapsulated. This work provides the first fully quantitative evidence that microcompartment-based encapsulation can be used to divert pathway flux to the encapsulated pathway. It provides insight into why certain pathways are encapsulated natively and could be leveraged for metabolic engineering applications.

23 August 2025 in bioRxiv
Verified
Preprint
Open access
BPBrett Palmero
Brett Palmero
CCChristina Catlett
Christina Catlett
CACharlotte Abrahamson
Charlotte Abrahamson
SSSasha Shirman
Sasha Shirman
CMCarolyn Mills
Carolyn Mills
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek
Biomanufacturing is a promising strategy for sustainable chemical production. However, challenges such as cofactor competition and low pathway flux prevent competitive titers. Some bacteria address these challenges by encapsulating metabolic pathways in bacterial microcompartments (MCPs), many of which contain dedicated cofactor recycling enzymes. We sought to determine how pathway cofactor recycling and intermediate sequestration in MCPs benefit pathway performance using an in vitro assay and kinetic model of the 1,2-propanediol utilization (Pdu) system. Guided by model simulations, we performed experimental design to characterize permeability, a key and difficult-to-measure property of MCPs. Using our model and measurements of metabolite concentrations over time, we estimate MCP permeability values in the range of 10 −5 cm/s. We also demonstrated that NAD+/NADH recycling in the Pdu MCP benefits increased pathway flux. This study integrates experiments and systems modeling to advance our understanding of why pathways are encapsulated and to inform bioengineering applications.

4 August 2020 in F1000Research
Verified
Journal Article
Open access
PDF file
ASAnna Sandler
Anna Sandler
JAJonathan Anderson
Jonathan Anderson
ABAriane Balaram
Ariane Balaram
YGYoan Ganev
Yoan Ganev
SGSamuel Gascoigne
Samuel Gascoigne
WCWilliam H. Conrad
William H. Conrad
Background:Gene silencing by CpG island hypermethylation often plays a role in colorectal cancer (CRC) progression. Certain regions of the genome, called high confidence differentially-methylated regions (DMRs), are consistently hypermethylated across numerous patient samples. Methods:In this study, we used bioinformatics and bisulfite PCR sequencing of HCT-116 cells to investigate methylation levels at DMRs in the promoters of six genes:DKK3, EN1, MiR34b, SDC2, SPG20, andTLX1. We then investigated whether the anti-cancer drug decitabine, had a demethylating effect at these promoter regions. Results:We found that hypermethylation correlated with lack of transcriptional enhancer binding in these six regions. Importantly, we observed that for all DMRs, decitabine significantly reduced CpG methylation. Decitabine also reduced clonogenic survival, suggesting that there is a correlation between lower CpG island methylation levels and reduced cancerous properties. Conclusions:Our study provided single-nucleotide resolution and revealed hypermethylated CpG sites not shown by previous genome-wide methylation studies. In the future, we plan to perform experiments that demonstrate a causal link between promoter hypermethylation and carcinogenesis and that more accurately model treatments in CRC patients.

23 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MJMadeline R. Joseph
Madeline R. Joseph
BPBrett J. Palmero
Brett J. Palmero
NKNolan W. Kennedy
Nolan W. Kennedy
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek
Crude glycerol is an underutilized waste stream. Viable routes for converting it to 1,3-propanediol (1,3-PDO) can conserve important resources and add value to its supply chain. Biological methods are appealing because they can circumvent expensive preprocessing steps while operating under mild conditions. Here, we show that the propanediol utilization pathway of Salmonella enterica serovar Typhimurium LT2 can be used to convert glycerol, including unprocessed crude glycerol, into 1,3-PDO under aerobic conditions in minimal media. Additionally, we demonstrate that high concentrations of expensive cofactors are not necessary to achieve optimal production titers. This study lays the groundwork for continual iteration on this pathway for bioprocess development. Key points: S. enterica can produce 1,3-propanediol from crude glycerol alone Glycerol-to-1,3-propanediol conversion is dependent on expression of the propanediol utilization (Pdu) pathway Sub-saturating concentrations of exogenous vitamin B 12 can boost cell growth and 1,3-propanediol yield

11 September 2026 in ACS Synthetic Biology
Verified
Journal Article
Closed access
MJMadeline R. Joseph
Madeline R. Joseph
BPBrett J. Palmero
Brett J. Palmero
NKNolan W. Kennedy
Nolan W. Kennedy
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek

25 July 2025 in bioRxiv
Verified
Preprint
Open access
JMJacob Benjamin Miller
Jacob Benjamin Miller
CACharlotte H Abrahamson
Charlotte H Abrahamson
MLMarilyn F S Lee
Marilyn F S Lee
BPBrett J Palmero
Brett J Palmero
NKNolan W Kennedy
Nolan W Kennedy
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek
Materials are challenging to synthetically program down to the atom level. Nature, however, excels at creating hierarchical materials from nanoscale building blocks, a feat that remains a major challenge in synthetic systems. A deeper understanding of the molecular rules governing self-assembly would unlock the potential for designing genetically programmable materials with atomic precision. Hexameric bacterial microcompartment (BMC-H) proteins offer a powerful model system for exploring this question. These sequence-defined proteins naturally assemble into complex architectures and can be expressed biologically, making them ideal candidates for studying how minor sequence variations influence supramolecular structure. In this work, we leverage cell-free protein synthesis (CFPS) alongside immunostaining and super-resolution microscopy to investigate the self-assembly behavior of two BMC-H proteins, PduA and PduJ. We find that both proteins form micro- to millimeter scale structures when expressed in vitro. Further, we demonstrate how single point mutation changes lead PduA and PduJ to form significantly different supramolecular structures when produced using CFPS. These studies support the future exploration of self-assembling proteins as programmable scaffolds in broad materials applications.